Featured Research

from universities, journals, and other organizations

Montreal Researchers Announce New Vaccine Approach To Stimulate Regeneration After Spinal Cord Injuries

Date:
December 10, 1999
Source:
Mcgill University
Summary:
A team of scientists from the McGill University Health Centre (MUHC), McGill University and Université de Montréal today announced a major advance in the struggle to find a treatment for spinal cord injuries. "We have successfully tested a new vaccine approach to block molecules in the spinal cord that prevent nerve regeneration," says Dr. Samuel David of the Montreal General Hospital Research Institute.

Montreal: Monday, December 6, 1999 - A team of scientists from the McGill University Health Centre (MUHC), McGill University and Université de Montréal today announced a major advance in the struggle to find a treatment for spinal cord injuries.

Related Articles


"We have successfully tested a new vaccine approach to block molecules in the spinal cord that prevent nerve regeneration," says Dr. Samuel David of the Montreal General Hospital Research Institute, MUHC and the lead investigator on the project. "The regrowth we have obtained using this technique is far greater than any that has been reported previously. This is a significant advance in the field, and changes the way we think and work toward the development of therapeutic strategies to eventually treat spinal cord injuries in humans."

"Spinal cord injuries are often sustained by young adults leading to a lifetime of disability," points out Dr. Peter Braun of the Department of Biochemistry at McGill University. "Since there is no cure to repair damaged nerve fibres in the injured spinal cord, the paralysis, sensory loss and loss of bladder and bowel control are permanent. Research carried out by our group in Montreal revealed that there are several molecules that can inhibit and prevent nerve regeneration. Myelin, a fat rich insulating membrane that wraps around nerve fibres contains these inhibitory molecules. The vaccine approach we have tested is able to block these inhibitors without producing unwanted side effects."

Dr. Lisa McKerracher of the département de pathologie et biologie cellulaire at the Université de Montréal describes the advance as "a relatively non-invasive strategy to stimulate the animal¹s own immune system to produce antibodies against proteins that inhibit the regrowth of axons or nerve fibres." "Moreover," she continues, "this vaccine approach allowed us to target many types of inhibitors not just one as has been the case in the past."

The developments announced today by Drs. David, McKerracher and Braun were published in the November issue of the international Neuroscience journal - Neuron. Their findings were also selected as one of three papers on nerve regeneration to receive special attention at last month¹s international meeting of the Society for Neuroscience in Miami.

Dr. David says that the next step towards making this discovery suitable for clinical use will be to identify other inhibitors. Then a cocktail of purified inhibitors can be tested in the laboratory for use as a vaccine in humans. "But there is much basic science work and testing ahead of us before we reach that stage," he cautions. "However, this is an important milestone toward the development of a treatment for spinal cord injuries."


Story Source:

The above story is based on materials provided by Mcgill University. Note: Materials may be edited for content and length.


Cite This Page:

Mcgill University. "Montreal Researchers Announce New Vaccine Approach To Stimulate Regeneration After Spinal Cord Injuries." ScienceDaily. ScienceDaily, 10 December 1999. <www.sciencedaily.com/releases/1999/12/991210081125.htm>.
Mcgill University. (1999, December 10). Montreal Researchers Announce New Vaccine Approach To Stimulate Regeneration After Spinal Cord Injuries. ScienceDaily. Retrieved March 29, 2015 from www.sciencedaily.com/releases/1999/12/991210081125.htm
Mcgill University. "Montreal Researchers Announce New Vaccine Approach To Stimulate Regeneration After Spinal Cord Injuries." ScienceDaily. www.sciencedaily.com/releases/1999/12/991210081125.htm (accessed March 29, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Sunday, March 29, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

S. Leone in New Anti-Ebola Lockdown

S. Leone in New Anti-Ebola Lockdown

AFP (Mar. 28, 2015) — Sierra Leone imposed a three-day nationwide lockdown Friday for the second time in six months in a bid to prevent a resurgence of the deadly Ebola virus. Duration: 01:17 Video provided by AFP
Powered by NewsLook.com
These Popular Antibiotics Can Cause Permanent Nerve Damage

These Popular Antibiotics Can Cause Permanent Nerve Damage

Newsy (Mar. 27, 2015) — A popular class of antibiotic can leave patients in severe pain and even result in permanent nerve damage. Video provided by Newsy
Powered by NewsLook.com
WH Plan to Fight Antibiotic-Resistant Germs

WH Plan to Fight Antibiotic-Resistant Germs

AP (Mar. 27, 2015) — The White House on Friday announced a five-year plan to fight the threat posed by antibiotic-resistant bacteria amid fears that once-treatable germs could become deadly. (March 27) Video provided by AP
Powered by NewsLook.com
House Ready to Pass Medicare Doc Bill

House Ready to Pass Medicare Doc Bill

AP (Mar. 26, 2015) — In rare bipartisan harmony, congressional leaders pushed a $214 billion bill permanently blocking physician Medicare cuts toward House passage Thursday, moving lawmakers closer to resolving a problem that has plagued them for years. (March 26) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins